Man Group’s Ginkgo Bioworks DNA Stock Holding History

Man Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Sell	24,208 -84,909	-78%	-$710K	﹤0.01%	2235
2026 Q1	$669K	Buy	+109,117	New	+$908K	﹤0.01%	1983
2024 Q2	–	Sell	-18,946	Closed	-$879K	–	2073
2024 Q1	$879K	Buy	18,946 +17,110	+932%	+$886K	﹤0.01%	1595
2023 Q4	$124K	Buy	+1,836	New	+$112K	﹤0.01%	1965
2023 Q3	–	Hold	0	–	–	–	1877
2023 Q1	–	Hold	0	–	–	–	1958

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Man Group's DNA Position: Q2 2026 in Review

Man Group reduced its Ginkgo Bioworks (DNA) stake by 78% in Q2 2026, selling an estimated $710K and leaving 24,208 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Man Group first reported a position in DNA in Q4 2023 and has held it in 4 quarters since. The position peaked at $879K in Q1 2024. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Man Group held 24,208 shares of Ginkgo Bioworks worth $240K as of Q2 2026.
Man Group sold 84,909 Ginkgo Bioworks shares in Q2 2026, an estimated $710K.
Ginkgo Bioworks made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2235 holding.
Man Group first reported a position in Ginkgo Bioworks in Q4 2023 and has held it in 4 quarters since.
Man Group's Ginkgo Bioworks position peaked at $879K in Q1 2024.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.